PG4 for pneumococcal infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 May 2026: Trial started, NCT07573462
  2. 7 May 2026: Trial registered, NCT07573462

The trials

NCT07573462: A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

State
Under way
Phase
Phase 3
People
2,400 planned
Started
4 May 2026
Primary completion
30 Dec 2028
Arms
PG4 (intramuscular)
Results
None posted
  1. 4 May 2026: Trial started
  2. 7 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.